Evolutionary Therapy for Rhabdomyosarcoma
Phase: Recruiting
Condition(s): Rhabdomyosarcoma
NCT Number: NCT04388839 Other Study ID Number(s): MCC20339
What Is the Purpose of This Study?
This clinical trial will evaluate four different strategies of chemotherapy schedules in newly diagnosed participants with metastatic fusion positive (alveolar) rhabdomyosarcoma.
Who Can Take Part in This Study?
- People with new diagnosis of rhabdomyosarcoma with distant metastatic disease and no prior systemic chemotherapy.
What Will Happen During This Study?
The participant and their physician will choose from: